A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...

According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to their critical treatment, paving the way for the development of more effective ...

This spontaneous mutation pattern explains why hemophilia A can appear unexpectedly in families with no known bleeding disorders. Genetic testing now allows precise identification of the specific ...

China recently approved its first gene therapy for the rare genetic disorder hemophilia B, drawing renewed attention to this often-overlooked condition. Hemophilia is a rare but serious inherited ...

Subsequent studies by other investigators confirmed those early results, ultimately leading to the FDA approval of ...

Hemophilia A Market Trends The report provides a detailed analysis of the current hemophilia A marketed drugs and late-stage pipeline drugs ...

A new portable device developed by Rutgers University researchers can detect genetic mutations linked to hereditary ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's ...